ImmunityBio, Inc. IBRX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from ImmunityBio, Inc.’s reported figures.
Based on trailing twelve months.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s asset turnover?
- ImmunityBio, Inc. (IBRX) reported asset turnover of 0.3× in Q1 2026.
- How has ImmunityBio, Inc.'s asset turnover changed year-over-year?
- ImmunityBio, Inc.'s asset turnover increased by 234.9% year-over-year, from 0.1× to 0.3×.
- What is the long-term trend for ImmunityBio, Inc.'s asset turnover?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s asset turnover has grown at a 127.5% compound annual growth rate (CAGR), from 0× to 0.3×.
- What does asset turnover mean?
- How many sales dollars the company generates from each dollar of assets.
- How do you interpret asset turnover?
- Higher turnover means a more sales-efficient asset base. Low-margin businesses (retail, distribution) compete on high turnover; high-margin ones (software, luxury) on margin.
- How does asset turnover compare across companies?
- Compare within an industry — turnover differences across sectors reflect business models, not performance.